+Compare
VREX
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
764.37M

VREX Varex Imaging Corp Forecast, Technical & Fundamental Analysis

a manufactures of X-ray tubes, flat panel detectors, connectors and accessories for imaging as well as workstations and software for computer-aided diagnostics and image processing

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for VREX with price predictions
08:00 PM EDT Sep 28, 2023

VREX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for VREX turned positive on September 14, 2023. Looking at past instances where VREX's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VREX's RSI Oscillator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where VREX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VREX advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

VREX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on VREX as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VREX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VREX entered a downward trend on September 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VREX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.438) is normal, around the industry mean (24.898). P/E Ratio (26.247) is within average values for comparable stocks, (79.320). Projected Growth (PEG Ratio) (0.652) is also within normal values, averaging (6.382). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.857) is also within normal values, averaging (58.126).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VREX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.32B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -8%. FEMY experienced the highest price growth at 868%, while AVGR experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 137%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was 149%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 67
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

VREX is expected to report earnings to fall 8.11% to 34 cents per share on November 14

Varex Imaging Corp VREX Stock Earnings Reports
Q3'23
Est.
$0.34
Q2'23
Beat
by $0.09
Q1'23
Beat
by $0.11
Q4'22
Beat
by $0.04
Q3'22
Beat
by $0.09
The last earnings report on August 01 showed earnings per share of 37 cents, beating the estimate of 28 cents. With 232.54K shares outstanding, the current market capitalization sits at 764.37M.
A.I. Advisor
published General Information

General Information

a manufactures of X-ray tubes, flat panel detectors, connectors and accessories for imaging as well as workstations and software for computer-aided diagnostics and image processing

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1678 South Pioneer Road
Phone
+1 801 972-5000
Employees
2300
Web
https://www.vareximaging.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POSAX7.52N/A
N/A
Principal Global Real Estate Sec A
VAFRX18.70-0.03
-0.16%
Invesco American Franchise R
IMOZX22.05-0.06
-0.27%
Voya MidCap Opportunities R6
APDNX11.99-0.07
-0.58%
Artisan Select Equity Advisor
FAVAX21.85-0.13
-0.59%
Fidelity Advisor® Equity Value A

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with AVNS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then AVNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
-0.69%
AVNS - VREX
46%
Loosely correlated
-0.98%
ARAY - VREX
39%
Loosely correlated
-0.37%
ATRC - VREX
39%
Loosely correlated
-0.25%
QTRX - VREX
36%
Loosely correlated
-2.93%
IDXX - VREX
35%
Loosely correlated
+0.07%
More

Groups containing VREX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
-0.69%
medical research
(undefined stocks)
41%
Loosely correlated
-0.13%
medical service
(undefined stocks)
40%
Loosely correlated
-0.06%
Medical Specialties
(undefined stocks)
40%
Loosely correlated
+0.46%
Medical Specialties
(undefined stocks)
40%
Loosely correlated
+0.46%
imaging
(undefined stocks)
39%
Loosely correlated
-0.35%
More